Silicon Laboratories Inc. carries no debt; cash flow comfortably covers obligations.

Silicon Laboratories Inc. has insufficient data to evaluate this check.

Silicon Laboratories Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Silicon Laboratories Inc. has insufficient data to evaluate this check.

Silicon Laboratories Inc. has a net cash position, so leverage is healthy.

Silicon Laboratories Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Silicon Laboratories Inc.'s profit margin has increased (-81.23%) in the last year from -32.69% to -6.13%, signaling increasing performance

Silicon Laboratories Inc.'s short-term assets of $674.02M exceed its short-term liabilities of $143.79M

Silicon Laboratories Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Silicon Laboratories Inc.'s return on equity of -4.66%, is lower than 15.00%, indicating bad performance

Silicon Laboratories Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Silicon Laboratories Inc. had positive net income in only 2 out of 5 years, indicating unstable earnings

Silicon Laboratories Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Silicon Laboratories Inc. has a free cash flow yield of 0.91%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Silicon Laboratories Inc.'s yearly earnings has increased -66.02% since last year from $-191.01M to $-64.91M, signaling increasing performance

Silicon Laboratories Inc. has insufficient data to evaluate this check.

ROIC -3.91% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Silicon Laboratories Inc.'s 3-year revenue CAGR of -8.49% is negative, indicating declining revenue over the past 3 years

Silicon Laboratories Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Silicon Laboratories Inc. had positive ROE in only 2 out of 5 years, indicating inconsistent returns on equity

Silicon Laboratories Inc. is overvalued relative to its fair value price of 25.42 based on Discounted Cash Flow model

Silicon Laboratories Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Silicon Laboratories Inc. is overvalued relative to its fair value price of 7.05 based on EBITDA multiple model

Silicon Laboratories Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Silicon Laboratories Inc. is overvalued relative to its fair value price of -21.15 based on Earnings Fair Value model

Silicon Laboratories Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Silicon Laboratories Inc. has a price-to-book ratio of 6.55x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Silicon Laboratories Inc. has a price-to-sales ratio of 8.77x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue